Ross V. ChikarmaneMoney in PoliticsA data-driven profile on major sources of campaign financing for U.S. Congressional & Presidential elections and their influence on…May 13, 2022May 13, 2022
Ross V. ChikarmaneA Memoir on Building Hopkins Biotech PodcastHow we built the Hopkins Biotech Podcast — based out of Johns Hopkins School of Medicine — and grew it from a simple idea to a program…Mar 19, 2022Mar 19, 2022
Ross V. ChikarmanePhD Career Prospects by the NumbersA data-driven profile on the types of work that STEM PhDs pursue and their pay scales, based on employment statistics from the National…Nov 6, 2021Nov 6, 2021
Ross V. ChikarmaneinThe StartupBiotech Investment Surges in 2020In honor of the last trading day of 2020, let’s review this year in biotech investing.Dec 31, 20201Dec 31, 20201
Ross V. ChikarmaneinThe StartupFoghorn Therapeutics Breaks New Ground in Cancer EpigeneticsOriginally published on December 2, 2020 in Johns Hopkins’ blog Biomedical Odyssey (link)Dec 25, 2020Dec 25, 2020
Ross V. ChikarmaneinThe StartupNext Generation Cancer Diagnostics Revolutionize Patient CareOriginally published on October 5, 2020 in Johns Hopkins’ blog Biomedical Odyssey (link)Dec 25, 2020Dec 25, 2020
Ross V. ChikarmaneHow to Master a New TechniqueOriginally published on August 3, 2020 in Johns Hopkins’ blog Biomedical Odyssey (link)Dec 25, 2020Dec 25, 2020
Ross V. ChikarmaneWhy Leave Career Fulfillment Up to Chance?Originally published on June 24, 2020 in Johns Hopkins’ blog Biomedical Odyssey (link) to promote the Hopkins Biotech Podcast, which we…Dec 25, 20201Dec 25, 20201
Ross V. ChikarmaneEvery Challenge Is an OpportunityOriginally published on April 21, 2020 in Johns Hopkins’ blog Biomedical Odyssey (link)Dec 25, 2020Dec 25, 2020
Ross V. ChikarmaneAn Alzheimer’s Drug Rises from the AshesOriginally published on April 11, 2020 in Hopkins Biotech Network’s newsletter The Transcript (link)Dec 25, 2020Dec 25, 2020
